CREATION Health Readmission Risk Assessment Tool

Last updated: February 6, 2020
Sponsor: AdventHealth
Overall Status: Completed

Phase

N/A

Condition

Heart Failure

Hip Replacement

Hypercholesterolemia

Treatment

N/A

Clinical Study ID

NCT03424382
1004998
  • Ages > 21
  • All Genders

Study Summary

This study occurs in two phases. Phase 1 involves initial item development and measurement validation of a new tool for identifying hospitalized patients at high risk for preventable readmission. Primary tasks include item construction and content validation, data collection, analysis, and instrument refinement. Phase 2 involves administering the refined instrument to a new group of patients to determine final item content for the instrument, its factor structure, and its predictive validity.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Primary or secondary admission diagnosis of heart failure, chronic obstructivepulmonary disease, acute myocardial infarction, coronary artery bypass graft,pneumonia, total knee or hip replacement, or stroke.

  • Age 21 and over

  • Able to provide informed consent

  • Able to speak and read English

  • Able to complete an electronic survey or relay answers to questions to another partywho may complete the survey for the participant

  • Resides in Central Florida and anticipates continued residence in Central Florida forthe next 120 days

  • Planned discharge to a non-hospital or residential care environment

Exclusion

Exclusion Criteria:

  • Under age 21

  • Does not speak or read English

  • Permanent residence is outside Central Florida

  • Not of cognitive capacity to provide valid responses

  • Dementia or cognitive impairment that renders subject unable to provide informedconsent

  • Prescribed a known psychoactive medication that might reasonably affect the ability ofthe participant to provide valid responses

Study Design

Total Participants: 1218
Study Start date:
May 15, 2017
Estimated Completion Date:
November 26, 2019

Study Description

Participants will complete the instrument on an electronic device provided by research staff in the hospital room. If an individual is unable to complete the instrument, the participant may have another individual input answers on the electronic device. Hospitalized patients (n = 1240: 620 in Phase 1 and 620 in Phase 2) with a variety of chronic diseases will be recruited into the study. Study coordinators will recruit participants with the following diagnoses: heart failure, chronic obstructive pulmonary disease, acute myocardial infarction, coronary artery bypass graft, pneumonia, total knee or hip replacement, and stroke. These diagnoses were chosen because of the frequency with which patients are readmitted after discharge.

Connect with a study center

  • Florida Hospital

    Orlando, Florida 32804
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.